Social Prescribing for Advancing Resilience in Kids: A Pilot Study of Social Prescribing

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age11-17
SponsorUniversity of Ottawa

About this trial

The goal of this clinical trial is to learn if the Social Prescription (SP) intervention helps improve mental health and wellbeing in youth. It will also assess the feasibility and acceptability of implementing SP in a community setting. The main questions it aims to answer are:

* Is the SP intervention feasible and acceptable for youth, caregivers, and staff? * Does the SP intervention improve mental health outcomes, reduce stress, and increase wellbeing and social connectedness in youth?

Researchers will compare the Social Prescription (SP) intervention to an education control group to evaluate its effectiveness in improving youth mental health and wellbeing.

Participants will:

* Be randomized to receive either the SP intervention or be placed in an education control group * Complete wellbeing and mental health questionnaires at the beginning of the study and again after 12 weeks * Participate in qualitative interviews to share their experiences after participating in SP

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

between 11-17 years of age

on the waitlist for mental health services

are not an immediate safety threat to themselves or others as assessed by the HEADS ED questionnaire

Disqualifiers

Children < 11 years old

Adolescents > 17 years old

Trial design

Design model

Parallel

Treatments tested in this trial

  • Social Prescribing

    Behavioral

    A social prescribing intervention is a non-clinical approach to improving health and wellbeing by connecting individuals to community-based services and activities that address social, emotional, and practical needs. These may include arts programs, physical activity, peer support, volunteering, or nature-based activities. Facilitated by a link worker or navigator, social prescribing is tailored to the individual and aims to enhance mental health, reduce isolation, and support overall wellness beyond traditional medical care.

Treatment groups

170 Participants
are divided into 2 treatment groups
Group A: Social prescribing interventionExperimental treatment 1 intervention
Group B: Educational controlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Revised Children's Anxiety and Depression Scale

The Revised Children's Anxiety and Depression Scale (RCADS) is a self-report questionnaire that measures symptoms of anxiety and depression in children and adolescents aged 8 to 18.

Time frame
From enrollment to end of treatment or control period at 12 weeks.
2

Perceived Stress Scale

The Perceived Stress Scale is a widely used to help understand how different situations affect our feelings and our perceived stress.

Time frame
From enrollment to end of treatment or control period at 12 weeks.
3

Warwick-Edinburgh Mental Wellbeing Scale

The Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) was developed to enable the monitoring of mental wellbeing in the general population and the evaluation of projects, programmes and policies which aim to improve mental wellbeing.

Time frame
From enrollment to end of treatment or control period at 12 weeks
4

Social Connectedness Scale

The Social Connectedness Scale measures the extent to which individuals feel connected to others in their social environment.

Time frame
From enrollment to end of treatment or control period at 12 weeks

Secondary outcomes

1

Acceptability of Intervention Measure

The Acceptability of Intervention Measure evaluates how agreeable or satisfactory an intervention is perceived to be by participants or implementers.

Time frame
From enrollment to end of treatment or control period at 12 weeks
2

Intervention Appropriateness Measure

The Intervention Appropriateness Measure assesses the perceived relevance or suitability of an intervention for a specific setting or population.

Time frame
From enrollment to end of treatment or control period at 12 weeks
3

Feasibility of Intervention Measure

The Feasibility of Intervention Measure gauges how practical and possible it is to implement an intervention within a given setting.

Time frame
From enrollment to end of treatment or control period at 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Ottawa

Lead sponsor

Children's Hospital of Eastern Ontario Research Institute

Collaborator

This trial is not recruiting at the moment. You can still explore other options: